Guangzhou Wondfo Biotech Co., Ltd. (300482.SZ) has released its third quarter report for 2025, revealing that the company achieved an operating revenue of 1.69 billion yuan in the first three quarters, a year-on-year decrease of 22.52%. The net profit attributable to shareholders of the listed company was 134 million yuan, down 69.32% compared to the previous year. The net profit attributable to shareholders of the listed company, excluding non-recurring gains and losses, was 82.64 million yuan, a year-on-year decrease of 78.67%. Basic earnings per share stood at 0.28 yuan.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments